NO880141L - Forbedret fibrinolytisk blanding. - Google Patents

Forbedret fibrinolytisk blanding.

Info

Publication number
NO880141L
NO880141L NO880141A NO880141A NO880141L NO 880141 L NO880141 L NO 880141L NO 880141 A NO880141 A NO 880141A NO 880141 A NO880141 A NO 880141A NO 880141 L NO880141 L NO 880141L
Authority
NO
Norway
Prior art keywords
fibrinolytic
approx
enzyme
mixing
weight
Prior art date
Application number
NO880141A
Other languages
English (en)
Other versions
NO880141D0 (no
Inventor
Robert L Hunter
Alexander Duncan
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/045,459 external-priority patent/US4801452A/en
Priority claimed from PCT/US1987/001067 external-priority patent/WO1987006836A1/en
Application filed by Univ Emory filed Critical Univ Emory
Publication of NO880141D0 publication Critical patent/NO880141D0/no
Publication of NO880141L publication Critical patent/NO880141L/no
Priority to NO922262A priority Critical patent/NO922262D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

En blanding son effektivt oppleser blodklumper og reetable-. rer og oppretter blodstrømmen gjennom kransarterier eller andre blodkar hvor det har vært en trombose. Den fibrinolytiske blandingen ifølge foreliggende oppfinnelse består av et enzym, f.eks. streptokinase, urokinase, vevsplasminogenaktivator eller et annet fibrinolytisk enzym, og en overflateaktiv kopolymer. Sistnevnte kan vsre et etylenoksyd-propylenoksyd-kondensasjons-produkt med følgende generelle formel:. hvor a er et tall, slik at den hydrofobe delen representert ved (CH0), har en molekylvekt fra ca. 950 til 4000, fortrinnsvis fra 175til 4000, og b er et slikt tall at den hydrofile delen representert ved (CH0), utgjør fra ca. 50 til ca. 90 vekt% av forbindelsen.
NO880141A 1986-05-15 1988-01-14 Forbedret fibrinolytisk blanding. NO880141L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO922262A NO922262D0 (no) 1986-05-15 1992-06-09 Forbedret fibrinolytisk blanding

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86358286A 1986-05-15 1986-05-15
US4388887A 1987-04-29 1987-04-29
US07/045,459 US4801452A (en) 1986-05-15 1987-05-07 Fibrinolytic composition
PCT/US1987/001067 WO1987006836A1 (en) 1986-05-15 1987-05-08 Fibrinolytic composition

Publications (2)

Publication Number Publication Date
NO880141D0 NO880141D0 (no) 1988-01-14
NO880141L true NO880141L (no) 1988-03-14

Family

ID=27488885

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880141A NO880141L (no) 1986-05-15 1988-01-14 Forbedret fibrinolytisk blanding.

Country Status (2)

Country Link
MC (1) MC1856A1 (no)
NO (1) NO880141L (no)

Also Published As

Publication number Publication date
NO880141D0 (no) 1988-01-14
MC1856A1 (fr) 1988-12-19

Similar Documents

Publication Publication Date Title
DE3855096T2 (de) Hemmung von arteriellem thrombotischen Verschluss oder von Thrombo-Embolismus
Tamao et al. Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo
DE69322624D1 (de) Präparat zur behandlung und verhütung von bakteriellen infektionen,das chlordioxyd enthalt
NO844282L (no) Bloderstatningsmidler og fremgangsmaate for deres fremstilling
ES2009264A6 (es) Procedimiento de obtencion de una composicion fibrinolitica mejorada.
IE48478B1 (en) Enzyme derivatives for use in the treatment of venous thrombosis,compositions containing them and their preparation
ATE108206T1 (de) Gewebe-plasminogenaktivator.
JPS6236502B2 (no)
Randolph et al. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli
Dosekun et al. Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects
NO880141L (no) Forbedret fibrinolytisk blanding.
EP0624642B1 (en) Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
US4349630A (en) Heat-resistant water soluble urokinase derivative
Tyler A comparative study of the solvents commonly used to detect fibrin stabilisation
Nieuwenhuizen et al. Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin
EP0054919A2 (en) Artificial medical material
Wentzel et al. High toxicity of pure botulinum type D toxin
EP0242653B1 (en) Tpa-containing medical composition and use thereof
Lundin Acetylcholinesterase in goldfish muscles. Studies on some substrates and inhibitors
DE4442665A1 (de) Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
Epstein et al. Interaction of myosin and paramyosin
KR0127776B1 (ko) 신규한 단백질 분해효소의 cDNA 서열 및 그로 부터 유래된 단백질
IE922400L (en) Composition comprising an oxygen radical scavenger and a¹surface-active copolymer
Miller et al. Degradation of Fibrinogen by Proteolytic Enzymes
Suehiro et al. Inhibitory effect of staphylokinase on platelet aggregation